Core Laboratories N.V. provided earnings guidance for the third quarter of 2022. For the quarter, the company expected revenue to range from $123,000,000 to $129,000,000 and operating income of $10,100,000 to $13,300,000, yielding operating margins of approximately 9%. EPS for the third quarter of 2022 is expected to be $0.13 to $0.18.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.16 USD | +0.06% | +10.46% | +2.83% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.83% | 852M | |
+12.60% | 17.01B | |
0.00% | 7.43B | |
-10.61% | 2.74B | |
-30.24% | 1.77B | |
-3.73% | 1.15B | |
-4.78% | 1.09B | |
-12.62% | 817M | |
0.00% | 764M | |
-18.97% | 724M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Core Laboratories N.V. Provides Earnings Guidance for the Third Quarter of 2022